Product Information

PREGABALIN 150 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0583 per EA under NDC 64980041410. Its NADAC has been published 369 times since Oct 30, 2019.

FDA first approved this application on Jul 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PREGABALIN 150 MG CAPSULE

PREGABALIN
$0.0583per EA
DEA Schedule CV

Strength

150 mg/1

NDC

64980041410

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA210432

FDA Approved

7/19/2019

TE Code

AB

On Market Since

7/19/2019

Price Statistics

The NADAC for PREGABALIN 150 MG CAPSULE has been published 369 times since Oct 30, 2019, and over the history we have for it it has declined 65.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0583 per EA
All-time high$0.1773 (Jun 10, 2020)
All-time low$0.0489 (Jul 22, 2026)
52-week high$0.0585
52-week low$0.0489
Median price$0.0752
Average price$0.0892
Largest weekly change+32.6% (Aug 21, 2024)
Weeks tracked369
Tracking sinceOct 30, 2019

Price History

1W

-0.5%

1M

+7.5%

3M

+14.1%

6M

+15.3%

1Y

+5.5%

3Y

-13.1%

5Y

-34.8%

All

-65.9%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PREGABALIN 150 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 150 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.0583 per EA (NDC 64980041410), effective Nov 18, 2026.

How has the price of PREGABALIN 150 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PREGABALIN 150 MG CAPSULE has declined 65.9%. It has been tracked across 369 weekly CMS publications since Oct 30, 2019.

What are the highest and lowest recorded NADAC prices for PREGABALIN 150 MG CAPSULE?

Since Oct 30, 2019, the NADAC for PREGABALIN 150 MG CAPSULE has ranged from a low of $0.0489 (Jul 22, 2026) to a high of $0.1773 (Jun 10, 2020), with a median of $0.0752 per EA.

Are there cheaper alternatives to PREGABALIN 150 MG CAPSULE?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 150 MG CAPSULE, is $0.0550 per EA — about 6% below PREGABALIN 150 MG CAPSULE.

Who manufactures PREGABALIN 150 MG CAPSULE?

PREGABALIN 150 MG CAPSULE (NDC 64980041410) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.